The record-linkage was initiated by Chief Scientist Office, Scotland (reference CZH/4/328) and Privacy Advisory Committee Approved study (reference RM/sh/ISD 13-06). Data are available from Scotland\'s Information Services Division, a division of National Services Scotland, part of NHS Scotland, for researchers who meet the criteria for access to confidential information; contact Dr. Lorna Ramsay (<lorna.ramsay@isd.csa.scot.nhs.uk>) or Michael Fleming (<michael.fleming@nhs.net>).

Introduction {#sec001}
============

Injecting drug users experience significantly higher mortality rates \[[@pone.0141073.ref001]--[@pone.0141073.ref013]\], and identifying opportunities of intervention, such as upon release from prison or expiry of methadone prescription \[[@pone.0141073.ref005], [@pone.0141073.ref010]\], are important for public health policy.

Scotland has invested in record linkage for drug users to monitor blood born viruses and prevalence of injecting drug users. Using record linkage, Merrall et al. \[[@pone.0141073.ref014]\] added to the literature of drug user mortality by showing that drug treatment clients were at increased risk of drugs-related death (DRD) within 28 days after hospital-discharge in Scotland in 1996--2006 (21 DRDs per 1,000 person-years (pys); 95% CI: 18, 25).

In this article, we first validate the findings by Merrall et al. \[[@pone.0141073.ref014]\] for 1996--2006 by investigating SDMD clients' DRD-risk by time after hospital-discharge in 2006--2010. The injector population is changing over time, as the progression and initiation of injectors changes through social change and public health interventions, so it is important to validate past findings. Secondly, using the entire 1996--2010 SDMD cohort with the increased person-years of follow-up--and hence increased statistical power- we are able to investigate more detailed hospital episode characteristics, such as duration of hospitalization and main discharge-diagnosis.

We confirm SDMD clients continue to experience higher drugs-related mortality rates after hospital-discharge, and further that having been an injection drug user better identifies those at highest DRD-risk soon after hospital-discharge than duration of hospital-stay or main discharge-diagnosis.

Methods {#sec002}
=======

The study of hard-to-reach populations, such as people who inject drugs, has been hugely facilitated by linkage between administrative records and confidential health registers, see for example \[[@pone.0141073.ref003], [@pone.0141073.ref004], [@pone.0141073.ref006], [@pone.0141073.ref007], [@pone.0141073.ref009]--[@pone.0141073.ref013]\]. Scotland's Information Services Division holds the Scottish Drugs Misuse Database (SDMD), which records all registrations in Scotland for drug treatment or support. By a variation on the Privacy Advisory Committee permissions for Scotland's surveillance of the late sequelae after hepatitis C virus diagnosis \[[@pone.0141073.ref015]\], we could access linked data for the present study of SDMD clients' DRDs to 31 March 2010.

Study population and data sources {#sec003}
---------------------------------

For each drug treatment registration in Scotland, the SDMD holds limited identifying information: sex, date of birth, forename initial, first and fourth letter of the surname, and postcode sector of residence. Data are also held on risk behaviors such as illicit drugs used, reported misuse of alcohol, and injecting drug user status at the time of SDMD registration. Linked SDMD records were available on 98,388 individuals who attended drug treatment services between 1 April 1996 and 31 March 2010.

Deaths, hospital episodes and hepatitis C virus diagnoses of individuals registered on the SDMD during April 1996 through March 2010 were identifiable through linkages with the national registers held respectively by Information Services Division, National Records of Scotland (formerly the General Register Office for Scotland) and Health Protection Scotland. Records were linked by Information Services Division using a probabilistic approach on the available identifying information at the time of linkage. Note that these identifiers may have changed between the linkages performed in 2006 and 2010. For each SDMD client, potentially corresponding death, hospital records and hepatitis C virus records were ranked according to a linkage score which was based on a probabilistically-weighted combination of the occurring identifiers. The top-ranked match would be successful if the score exceeded a pre-determined threshold (see Merrall \[[@pone.0141073.ref016]\] for further details).

The linked dataset was anonymized before transfer to Medical Research Council Biostatistics Unit for analysis. This anonymization, together with updating of contributory records, explains why linked-records for the same individual cannot assuredly be matched between successive linkages, such as for the 1996--2006 and updated 1996--2010 SDMD cohorts. Information Services Division has previously estimated its procedure to have an error rate (either false positives or false negatives) of less than 5% \[[@pone.0141073.ref017]\]. However, low-level inconsistencies inevitably remain. Moreover, due to the updating of the contributory linkable records, the SDMD cohort for 1996--2006 is now reckoned as 74,654 registered clients (previously 69,457 \[[@pone.0141073.ref014]\]). There are thus actual differences in the client, DRD, and person-year counts from those reported by Merrall et al. \[[@pone.0141073.ref014]\] for 1996--2006 but these differences have had no implications for the inferences drawn, which are robust.

Statistical analysis {#sec004}
--------------------

We investigated DRDs as nationally defined by Jackson \[[@pone.0141073.ref018]\] and National Records of Scotland, which comprise deaths involving drugs or attributed to one's drug dependence and have the following groupings: mental and behavioral disorders due to psychoactive substance misuse; accidental poisoning; intentional self-poisoning by drugs, medicaments and biological substances; assault by drugs, medicaments and biological substances; and events of undetermined intent, poisoning. See [Table 1](#pone.0141073.t001){ref-type="table"} for the specific International Classification of Disease codes (9^th^ & 10^th^ version) corresponding to each grouping.

10.1371/journal.pone.0141073.t001

###### ICD codes for cause of death or hospital discharge.

![](pone.0141073.t001){#pone.0141073.t001g}

  Classification                                                                ICD 9                               ICD 10
  ----------------------------------------------------------------------------- ----------------------------------- ------------------------------------
  Infectious and parasitic diseases                                             001--139                            A00--B99
  Cancer                                                                        140--208                            C00--C97
  Endocrine, nutritional and metabolic diseases                                 240--279                            E00--E89
  Mental and behavioural disorders                                              290--319, Excluding: 305.2--305.9   F00--F99, Excluding: F11--F16, F19
  Diseases of the nervous system                                                320--389                            G00--G99
  Diseases of the circulatory system                                            390--459                            I00--I99
  Diseases of the respiratory system                                            460--519                            J00--J99
  Diseases of the digestive system                                              520--579                            K00--K93
  Accidental                                                                    E800--E949, Excluding: E850--E858   V01--X59
  (non-DRD) Suicide                                                             E950.6--E959                        X65--X84
  Homicide                                                                      E960--E969, Excluding: E962.0       X86--Y09
  Drugs-related death[^a^](#t001fn002){ref-type="table-fn"}                                                         
   Mental and behavioural disorders due to psychoactive substance misuse        292, 304, Excluding: 304.6          F11--F16, F19
   Accidental poisoning                                                         E850--E858                          X40--X44
   Intentional self-poisoning by drugs, medicaments and biological substances   E950.0--E950.5                      X60--X64
   Assault by drugs, medicaments and biological substances                      E962.0                              X85
   Events of undetermined intent, poisoning                                     E980.0--E980.5                      Y10--Y14
  Drugs-related morbidity[^b^](#t001fn003){ref-type="table-fn"}                                                     
   Poisoning by drugs, medicaments and biological substances                    960--976                            T36--T50
   Mental and behavioural disorders due to psychoactive substance misuse        292, 304 excluding 304.6            F11--F16, F19

Abreviations: DRD, drugs-related death; ICD, International Classification of Disease

^a^ Any codes corresponding to drugs-related causes were excluded from other categories, so all are mutually exclusive

^b^ Category used only for hospital discharge diagnoses

Each hospital record corresponds to an episode of care within a general/acute or mental health specialty, respectively, in Scotland. The record is generated when a patient is discharged or transferred between hospitals, specialties or consultants \[[@pone.0141073.ref019]\], and the duration of an episode may range from a day-visit up to a stay of several months. Hence, a single hospital-stay may comprise a series of episodes. Therefore, for each SDMD client, serial hospital episodes with overlapping or matching end- and start-dates were coalesced as a single hospital-stay which began at the set's earliest start-date and ended on the latest end-date.

Duration of hospital-stay was computed as 'latest end-date minus earliest start-date', and is thus measured in whole days with respect to the recorded admission and discharge dates. The majority of hospital-stays were of one day or less, a large number were computed as zero-length. Within the data it is not possible to derive an exact admission time, so we cannot distinguish between a short-stay that occurs over night and a stay for at least one day. Accordingly, duration was summarized as 0--1 days versus 2+ days, the former accounting for brief episodes that may or may not have included an over-night stay. The length of hospital-stay is highly skewed, and exhibits a so-called zero-inflated distribution (meaning there are many individuals with zero-length stays). With insufficient individuals to properly characterize longer stays, we dichotomize into (conservatively defined) day visits (0-1days) or longer (2+ days).

Hospital episodes are recorded with a main discharge-diagnosis and supplementary discharge diagnoses \[[@pone.0141073.ref004], [@pone.0141073.ref016]\]. We restrict attention to the main discharge-diagnosis of the last episode for each hospital-stay. The discharge codes for drug-related morbidity were classified using the same groupings as for drug-related mortality but with the addition of poisoning by drugs, medicaments and biological substances and mental and behavioral disorders due to psychoactive substance misuse. Further major categories of discharge-diagnosis were: infectious and parasitic diseases; cancer; endocrine, nutritional and metabolic diseases; mental and behavioral disorders---excluding those due to psychoactive substance misuse; diseases of the nervous system; diseases of the circulatory system; diseases of the respiratory system; diseases of the digestive system; and accidental. See [Table 1](#pone.0141073.t001){ref-type="table"} for the specific International Classification of Disease codes (9^th^ & 10^th^ version) corresponding to each grouping.

For the validation analysis, time-at-risk was from 1 April 2006 or the date of an individual's first attendance at drug treatment services if after 1 April 2006, until the earlier of date of death or end-of-study, 31 March 2010. Time since most recent hospitalization was categorized as: during hospitalization, within 28 days, 29--90 days, 91 days--1 year, \>1 year after discharge from most recent hospital-stay *versus* 'never admitted' (reference category). To be conservative, deaths which occurred on the end-date of a hospitalization were counted as hospitalized deaths. As in Merrall et al \[[@pone.0141073.ref014]\], hazard ratios from Cox proportional hazards analysis \[[@pone.0141073.ref020]\], with adjustment for time-dependent covariates, are also reported.

For adequately-powered secondary analyses of behavioral risks (ever injecting drug users; misuse of alcohol) and hospitalization covariates (length of stay; main discharge-diagnosis), we considered the 1996--2010 SDMD cohort in its entirety so that at least 30 DRDs in the 28 days after hospital-discharge might be available for analysis per discharge-diagnosis. Time-at-risk in secondary analyses was from the date of an individual's first attendance at drug treatment services after 1 April 1996 until the earlier of date of death or end-of-study, 31 March 2010.

All statistical analyses were conducted using R version 2.15.0 \[[@pone.0141073.ref021]\].

Results {#sec005}
=======

Characteristics of study population {#sec006}
-----------------------------------

[Table 2](#pone.0141073.t002){ref-type="table"} presents the characteristics of the study cohort, firstly for the SDMD clients first observed during the era originally studied, April 1996 to March 2006, and secondly for those first observed during April 2006 to March 2010. In the later era, an additional 23,734 individuals were newly registered in the SDMD cohort, with 14,474 subsequent hospital-stays and 168 DRDs during 50,453 person-years of follow-up. At their first registration in the 2006--2010 era, 68% were under 35 years of age (16,057) compared with 83% of those registered in the earlier era; 36% (8,605) had a recorded history of injection drug use (past or present) compared with 49% of those in 1996--2006.

10.1371/journal.pone.0141073.t002

###### Descriptive Statistics for characteristics at First SDMD Registration by Registration Era, SDMD Cohort, Scotland, 1996--2010.
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  Registration era:                                       Apr 1996--Mar 2006   Apr 2006--Mar 2010                
  ------------------------------------------------------- -------------------- -------------------- ------------ -----------
  New SDMD clients (i.e. number of first registrations)   74,654               23,734                            
   Male                                                   51,856               69.5%                16,931       71.3%
   Female                                                 22,798               30.5%                6,803        28.7%
    \< 25 years                                           31,326               42.0%                7,408        31.2%
   25--34 years                                           30,861               41.3%                8,649        36.4%
     **\> 35 years**                                      **12,467**           **16.7%**            **7,677**    **32.3%**
   Injected in past month                                 24,402               32.7%                4,536        19.1%
   Injected, but not in past month                        12,485               16.7%                4,069        17.1%
    **Never injected**                                    **33,533**           **44.9%**            **13,776**   **58.0%**
   Unknown                                                4,234                5.7%                 1,353        5.7%

Abbreviations: SDMD, Scottish Drugs Misuse Database

[Table 3](#pone.0141073.t003){ref-type="table"} presents descriptive statistics by follow-up era, with the 98,388 individuals contributing 334,421 person-years in the second follow-up era, 2006--2010, when there were 51,504 SDMD registrations, 78,658 hospital stays (based on 83,084 hospital-episodes and 11,818 psychiatric-episodes) and 2,544 deaths (including 1,114 DRDs). Across eras, DRDs account for about half of all deaths: 1409/2585 (55%) in 1996--2006 but 1114/2544 (44%) in 2006--2010. Non-drug-related suicide accounted for 11% (284) of deaths in the first era, but for only 6% (165) in the second. Conversely, diseases of the digestive system accounted for 6% (165) of deaths in the first era, but for 13% (341) in the second.

10.1371/journal.pone.0141073.t003

###### Descriptive Statistics for outcomes by Follow-up Era, SDMD Cohort, Scotland, 1996--2010.
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  Follow-up era:                                                 Apr 1996--Mar 2006   Apr 2006--Mar 2010                                                    
  -------------------------------------------------------------- -------------------- -------------------- ------------------------------------------------ -----------
  Total number of records                                        260,794              149,927                                                               
   SDMD                                                                               138,020                                                               51,504
   Hospital                                                                           96,465                                                                83,084
   Psychiatric                                                                        17,355                                                                11,818
   Hepatitis C virus diagnosis                                                        8,954                                                                 3,521
  Total Deaths                                                   2585                 2544                                                                  
    **Drugs-related deaths**                                     **1,409**            **54.5%**            **1,114**                                        **43.8%**
    **Non-DRD suicide** [^a^](#t003fn002){ref-type="table-fn"}   **284**              **11.0%**            **165**                                          **6.5%**
    **Diseases of the digestive system**                         **165**              **6.4%**             **341**                                          **13.4%**
    **Diseases of the circulatory system**                       **125**              **4.8%**             **193**                                          **7.6%**
    **Homicide**                                                 **102**              **3.9%**             60                                               2.4%
   Accidental                                                    93                   3.6%                 82                                               3.2%
   Infectious and parasitic diseases                             91                   3.5%                 65                                               2.6%
    **Cancer**                                                   69                   2.7%                 **130**                                          **5.1%**
    **Diseases of the respiratory system**                       64                   2.5%                 **103**                                          **4.0%**
   Mental and behavioral disorders                               60                   2.3%                 77                                               3.0%
   Endocrine, nutritional and metabolic diseases                 22                   0.9%                 25                                               1.0%
   Diseases of the nervous system                                16                   0.6%                 21                                               0.8%
  Total hospital-stays                                           94,449               78,658               (14,474)[^b^](#t003fn003){ref-type="table-fn"}   
  Person-years follow-up                                         371,117              334,421              (50,453)[^b^](#t003fn003){ref-type="table-fn"}   

Abbreviations: DRD, drugs-related death; SDMD, Scottish Drugs Misuse Database

^a^ Excluding DRD suicides which are included in the DRD total,

^b^ Restricted to individuals with first SDMD registration in 2006--2010 as in [Table 1(a)](#pone.0141073.t001){ref-type="table"}

The overall DRD-rate was 3.8 DRDs (95% CI: 3.6, 4.0) per 1,000 person-years in 1996--2006 but reduced to 3.3 DRDs (95% CI: 3.1, 3.5) per 1,000 person-years in 2006--2010.

### Validation analysis: drugs-related deaths by time since hospitalization {#sec007}

[Table 4](#pone.0141073.t004){ref-type="table"} summarizes DRD-rates by time since hospitalization in 1996--2006 and in the validation era of 2006--2010. In both eras, DRD-risk was highest during hospitalization but hospitalized DRD-rate decreased significantly from 74 DRDs per 1,000 person-years (95% CI: 61, 88) in 1996--2006 to 50 (95% CI: 39, 63) in 2006--2010. After discharge from a hospital-stay, DRD-rates per 1,000 person-years were consistent between eras: 24.6 and 22.5 within 28 days; 12.0 and 12.0 during 29--90 days; 8.3 and 8.6 for the remainder of the first year.

10.1371/journal.pone.0141073.t004

###### Drugs-related Death Rates by Follow-up Era and Time Since Hospital-discharge: Unadjusted, SDMD Cohort, Scotland, 1996--2010.
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  By follow-up era:               Apr 1996--Mar 2006   Apr 2006--Mar 2010                                                        
  ------------------------------- -------------------- -------------------- ---------- -------------- ----- --------- ---------- --------------
  Time since hospital-discharge                                                                                                  
  Never Admitted                  458                  257,643              **1.8**    (1.6, 2.0)     253   209,031   **1.2**    (1.1, 1.4)
  Hospitalized                    125                  1,697                **73.6**   (61.3, 87.8)   75    1,497     **50.1**   (39.4, 62.8)
  Within 28 days                  165                  6,714                **24.6**   (21.0, 28.6)   125   5,556     **22.5**   (18.7, 26.8)
  29--90 days                     131                  10,918               **12.0**   (10.0, 14.2)   107   8,903     **12.0**   (9.9, 14.5)
  91 days-- 1-year                271                  32,698               **8.3**    (7.3, 9.3)     235   27,306    **8.6**    (7.5, 9.8)
  1+ years                        259                  61,446               **4.2**    (3.7, 4.8)     319   82,128    **3.9**    (3.5, 4.3)

Abbreviations: DRD, drugs-related death; SDMD, Scottish Drugs Misuse Database; Pys, Person-years; CI, Confidence Interval

For each follow-up era [Table 5](#pone.0141073.t005){ref-type="table"} presents Cox Hazard Ratios by time since most recent hospitalization after adjustment for other DRD risk factors. In particular, note the influence of reported misuse of alcohol in addition to having ever injected.

10.1371/journal.pone.0141073.t005

###### Drugs-related Death Rates by Follow-up Era and Time Since Hospital-discharge: Adjusted Using Cox Proportional Hazards Regression With Calendar Time as the Underlying Time-scale, SDMD Cohort, Scotland, 1996--2010.
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  Follow-up era                           Apr 1996--Mar 2006   Apr 2006--Mar 2010               
  --------------------------------------- -------------------- -------------------- ----------- ----------------
  **Age**                                                                                       
  \< = 34 years (referent)                                                                      
  35+ years                               **1.16**             (1.03, 1.31)         **1.12**    (1.00, 1.27)
  **Sex**                                                                                       
  Female                                  **0.54**             (0.47, 0.62)         **0.58**    (0.50, 0.68)
  Male (referent)                                                                               
  **Injector status**                                                                           
  Inject in past month                    **1.25**             (1.10, 1.42)         **1.26**    (1.09, 1.45)
  Ever injected (referent)                                                                      
  Never injected                          **0.56**             (0.48, 0.66)         **0.64**    (0.54, 0.76)
  Unknown                                 **0.62**             (0.44, 0.87)         **0.61**    (0.42, 0.88)
  **Time since last SDMD registration**                                                         
  \<12 weeks                              **1.34**             (1.12, 1.60)         **1.64**    (1.29, 2.10)
  3--12 months                            **1.09**             (0.94, 1.26)         **1.24**    (1.02, 1.51)
  1--2 years (referent)                                                                         
  2--5 years                              **0.80**             (0.69, 0.92)         **0.89**    (0.75, 1.06)
  5+ years                                **0.44**             (0.34, 0.57)         **0.61**    (0.50, 0.74)
  **Misuse sedatives**                                                                          
  Yes                                     **1.08**             (0.97, 1.21)         **1.28**    (1.13, 1.46)
  No (referent)                                                                                 
  **Misuse stimulants**                                                                         
  Yes                                     **0.97**             (0.83, 1.13)         **1.04**    (0.89, 1.22)
  No (referent)                                                                                 
  **Misuse cannabis/tobacco**                                                                   
  Yes                                     **0.87**             (0.76, 0.98)         **0.80**    (0.69, 0.93)
  No (referent)                                                                                 
  **Misuse alcohol**                                                                            
  Yes                                     **1.48**             (1.26, 1.73)         **1.45**    (1.26, 1.67)
  No (baseline)                                                                                 
  **HCV diagnosis**                                                                             
  Yes                                     **1.31**             (1.15, 1.50)         **1.28**    (1.10, 1.48)
  No (referent)                                                                                 
  **Time since last hospitalised**                                                              
  Hospitalised                            **35.47**            (29.01, 43.35)       **32.92**   (25.33, 42.79)
  within 28 days                          **11.83**            (9.87, 14.18)        **15.09**   (12.12, 18.80)
  29--90 days                             **5.73**             (4.71, 6.98)         **8.01**    (6.36, 10.08)
  91 days-- 1 year                        **4.15**             (3.56, 4.84)         **5.90**    (4.91, 7.08)
  1+ years                                **2.44**             (2.09, 2.86)         **2.88**    (2.43, 3.41)
  Never admitted (referent)                                                                     

Abbreviations: SDMD, Scottish Drugs Misuse Database; CI, Confidence Interval

Consistently between 1996--2006 and 2006--2010 the hazard ratio is increased for reported misuse of alcohol (1.48 and 1.45) and for hepatitis C virus diagnosis (1.31 and 1.28); but reduced for females (0.54 and 0.58), and never-injectors (0.56 and 0.64). Relative to having never been admitted, adjusted hazard ratios by recency of hospital-stay were: 11.8 and 15.1 within 28 days; 5.7 and 8.0 during 29--90 days; and 4.2 and 5.9 for the remainder of the first year.

### Behavioral risk-factors versus duration of hospital-stay or main discharge-diagnosis {#sec008}

For the entire follow-up period of 1996--2010, [Table 6](#pone.0141073.t006){ref-type="table"} shows the DRD-rates by time since most recent hospital-discharge, according to SDMD clients' time-dependent ever injecting drug user status and [Table 7](#pone.0141073.t007){ref-type="table"} shows the DRD-rates by reported alcohol misuse.

10.1371/journal.pone.0141073.t006

###### Drugs-related Death Rates Soon After Hospital-discharge for Ever-IDU Behavioral Risk-factor, SDMD Cohort, Scotland, 1996--2010.
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  Injector-status:   Ever Injected   Never known to have injected                                                        
  ------------------ --------------- ------------------------------ ---------- -------------- ----- --------- ---------- --------------
  Never Admitted     512             250,555                        **2.0**    (1.9, 2.2)     199   216,119   **0.9**    (0.8, 1.1)
  Hospitalised       156             1,771                          **88.1**   (74.8,103.0)   44    1,423     **30.9**   (22.5, 41.5)
  Within 28 days     222             6,998                          **31.7**   (27.7, 36.2)   68    5,271     **12.9**   (10.0, 16.4)
  29--90 days        171             11,506                         **14.9**   (12.7, 17.3)   67    8,316     **8.1**    (6.2, 10.2)
  91 days-- 1 year   380             35,820                         **10.6**   (9.6, 11.7)    126   24,183    **5.2**    (4.3, 6.2)
  1+ years           458             92,362                         **5.0**    (4.5, 5.4)     120   51,212    **2.3**    (1.9, 2.8)

10.1371/journal.pone.0141073.t007

###### Drugs-related Death Rates Soon After Hospital-discharge for Reported Misuse of Alcohol Behavioral Risk-factor, SDMD Cohort, Scotland, 1996--2010.
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  Alcohol misuse:    Yes   No                                                            
  ------------------ ----- -------- ---------- -------------- ----- --------- ---------- --------------
  Never Admitted     132   60,437   **2.2**    (1.8, 2.6)     579   406,237   **1.4**    (1.3, 1.5)
  Hospitalised       41    653      **62.8**   (45.1, 85.2)   159   2,542     **62.6**   (53.2, 73.1)
  Within 28 days     89    2,655    **33.5**   (26.9, 41.3)   201   9,615     **20.9**   (18.1, 24.0)
  29--90 days        47    4,093    **11.5**   (8.4, 15.3)    191   15,728    **12.1**   (10.5, 14.0)
  91 days-- 1 year   113   11,324   **10.0**   (8.2, 12.0)    393   48,680    **8.1**    (7.3, 8.9)
  1+ years           105   20,493   **5.1**    (4.2, 6.2)     473   123,082   **3.8**    (3.5, 4.2)

Abbreviations: DRD, drugs-related death; SDMD, Scottish Drugs Misuse Database; Pys, Person-years; CI, Confidence Interval; IDU, Injecting Drug User

The DRD-rate during hospitalization is nearly three times higher for ever versus never injecting drug users (88 versus 31 per 1,000 person-years). Moreover, within 28 days of hospital-discharge ever injecting drug users experienced a DRD-rate of 32 per 1,000 person-years (95% CI: 27.7, 36.2) compared with 13 per 1,000 person-years (95% CI: 10.0, 16.4) for drug treatment clients who had never injected. Reported misuse of alcohol, although associated with as high a DRD-rate in the 28 days after hospital-discharge, was a less prevalent risk-factor and did not differentiate DRD-rate during hospitalization.

[Table 8](#pone.0141073.t008){ref-type="table"} shows DRD-rates within 28 days (and 90 days) after hospital-discharge by each of the following: ever injecting drug use and reported alcohol misuse (from Tables [6](#pone.0141073.t006){ref-type="table"} and [7](#pone.0141073.t007){ref-type="table"}); duration of hospital-stay and main discharge-diagnosis. There is no evident difference in DRD-rate according to duration of hospital stay (0--1 days versus 2+ days). However, we observe some variation in the DRD-rate by discharge-diagnosis.

10.1371/journal.pone.0141073.t008

###### Drugs-related Death Rates Soon After Hospital-discharge Within 28 and 90 Days After Hospital-discharge by Duration of Hospital-stay and Main Discharge-diagnosis Versus Ever-IDU and Reported Misuse of Alcohol, SDMD Cohort, Scotland, 1996--2010.
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  Soon after hospital-discharge                                           Within 28 days after discharge   Within 90 days after discharge                                                           
  ----------------------------------------------------------------------- -------------------------------- -------------------------------- ---------- -------------- --------- -------- ---------- --------------
  Rate for SDMD cohort, 1996--2010                                        290                              12,270                           23.6       (21.0, 26.5)   528       32,091   16.5       (15.1, 17.9)
  **By injector status**                                                                                                                                                                            
  Ever-IDU                                                                **222**                          6,998                            **31.7**   (27.7, 36.2)   **393**   18,504   **21.2**   (19.1, 23.3)
  Never or not known to have injected                                     68                               5,271                            **12.9**   (10.0, 16.4)   135       13,587   **9.9**    (8.3, 11.6)
  **By reported misuse of alcohol**                                                                                                                                                                 
  Yes                                                                     **89**                           2,655                            **33.5**   (26.9, 41.3)   **136**   6,748    **20.2**   (16.8, 23.5)
  No                                                                      201                              9,615                            **20.9**   (18.1, 24.0)   392       25,343   **15.5**   (13.9, 17.0)
  **By duration of hospital-stay**                                                                                                                                                                  
  0--1 day                                                                160                              6,781                            **23.6**   (20.1, 27.5)   277       17,957   **15.4**   (13.7, 17.4)
  2+ days                                                                 130                              5,488                            **23.7**   (19.8, 28.1)   251       14,134   **17.8**   (15.6, 20.1)
  **By main discharge-diagnosis**                                                                                                                                                                   
  Other diagnoses[^a^](#t008fn002){ref-type="table-fn"}                   93                               5,836                            **15.9**   (12.9, 19.5)   205       16,607   **13.1**   (11.4, 15.1)
  Drugs-related morbidity[^b^](#t008fn003){ref-type="table-fn"}           **74**                           1,899                            **39.0**   (30.1, 47.8)   **137**   4,996    **27.4**   (22.8, 32.0)
  Mental and behavioral disorders[^c^](#t008fn004){ref-type="table-fn"}   **54**                           1,503                            **35.9**   (27.0, 46.9)   **80**    3,782    **21.2**   (16.8, 26.3)
  Diseases of the respiratory system                                      22                               596                              **36.9**   (23.1, 55.9)   34        1,559    **21.8**   (15.1, 30.5)
  Cancer                                                                  3                                116                              **25.8**   (5.3, 75.4)    3         199      **15.1**   (3.1, 44.1)
  Infectious and parasitic diseases                                       6                                260                              **23.1**   (8.5, 50.2)    7         688      **10.2**   (4.1, 21.0)
  Diseases of the circulatory system                                      12                               576                              **20.8**   (10.8, 36.4)   21        1,502    **14.0**   (8.7, 21.4)
  Endocrine, nutritional and metabolic diseases                           3                                149                              **20.1**   (4.2, 58.9)    5         344      **14.5**   (4.7, 33.9)
  Diseases of the digestive system                                        22                               1,165                            **18.9**   (11.8, 28.6)   32        1,974    **10.8**   (7.4, 15.2)
  Diseases of the nervous system                                          1                                170                              **5.9**    (0.1, 32.8)    4         440      **9.1**    (2.5, 23.3)

Abbreviations: DRD, drugs-related death; SDMD, Scottish Drugs Misuse Database; Pys, Person-years; CI, Confidence Interval; IDU, Injecting Drug User

^a^ All diagnoses not included in specified groups

^b^ Diagnoses related to drug misuse, (a) Poisonings by drugs, medicaments & biological substances and (b) Mental & behavioral disorders due to psychoactive substance

^c^ All mental and behavioral disorders, excluding those due to psychoactive substances

Among discharge-diagnoses, only two---drug-related morbidity (for poisoning by drugs, medicaments and biological substances plus mental and behavioral disorders due to psychoactive substance misuse) and mental and behavioral disorders excluding those due to psychoactive substances---were associated with at least 30 DRDs within 28 days after discharge and also had high DRD-rates per 1,000 person-years, 39 (95% CI: 30.1, 47.8) and 36 (95% CI: 27.0, 46.9) respectively, as did diseases of the respiratory system, 37 (95% CI: 23.1, 55.9). Together, these top three discharge-diagnoses accounted for only 52% (150/290) of the SDMD cohort's DRDs within 28 days after hospital-discharge.

By contrast, ever injecting drug users accounted for 77% (222/290) of DRDs in the 28 days after hospital-discharge. The SDMD clients who reported misuse of alcohol had a correspondingly high DRD-rate soon after hospital-discharge but accounted for only 31% (89/290) of all SDMD clients' DRDs in the 28 days after hospital-discharge.

Ever injecting drug users' short-term risk can be summarized as one DRD (95% CI: 0.85, 1.11) in the 28 days after hospital-discharge per 400 discharged SDMD clients who had ever injected.

Discussion {#sec009}
==========

Our key confirmatory finding is that DRD-rates by time since most recent hospitalization remained significantly higher in the 28 days after hospital-discharge than at subsequent times post-discharge (with and without covariate adjustment). The SDMD cohort's DRD-rate while hospitalized had decreased in 2006--2010, but absolute DRD-risks soon after hospital-discharge remained similar across both periods.

New SDMD registrations in the validation period of 2006--2010 were different from those in the earlier registration period in important respects: a higher proportion of 2006--2010 registered clients were 35 years of age or older at registration than among clients whose first SDMD registration was in 1996--2006, and a higher proportion reported never having injected. This suggests that Scottish drug users are not only ageing but that newer clients are less likely to have been initiated into injecting.

The study disputed our hypothesis that individuals who are hospitalized for a longer time (at least overnight) may be at greater DRD-risk post-discharge due to loss of tolerance. However, the duration of hospital-stay was a highly skewed variable; with a few individuals experiencing very long (several months) periods. There was insufficient statistical power to properly investigate the effect of short versus long stay lengths. A further subdivision of duration of hospital-stay as 0--1 day, 2--6 days and 7+ days (results not shown) also showed no difference between stays of less than versus greater than one week.

The influence of main discharge-diagnosis on subsequent DRD-risk was also analyzed by grouping the codes into pre-specified categories as used previously by Merrall et al. \[[@pone.0141073.ref004]\]. We needed to consider the entire SDMD cohort in order to have sufficient power per discharge-category and, even so, only two main discharge-diagnoses exceeded 30 DRDs within 28 days after hospital-discharge. These two discharge-categories were drug-related morbidity and mental and behavioral disorders excluding psychoactive substance misuse. Even together with diseases of the respiratory system, these top three DRD-risk discharge-categories accounted for only 52% (150/290) DRDs in the 28 days after hospital-discharge.

By contrast, behavioral risk-factors were far more discriminatory with ever injecting drug use accounting for the vast majority (77%: 222/290) of DRDs in the 28 days after discharge. This finding gives added focus to Scotland's public health policy to make take-home naloxone (opiate antagonist) readily available, as well as training in its administration, not only in prisons and at drug treatment agencies but also at discharge from hospital, see \[[@pone.0141073.ref022]\] and \[[@pone.0141073.ref023]\]. Moreover, our new results suggest how hospital doctors can best target their harm reduction response \[[@pone.0141073.ref024]\]--not ineffectually according to patients' length of hospital-stay, nor too narrowly by concentrating on a few main discharge-diagnoses, but highly efficiently by focusing on those who have ever injected. For ever injecting drug users, we note that one DRD in the 28 days after hospital-discharge per 400 discharges is about half their estimated DRD-risk in the 28 days after prison-release \[[@pone.0141073.ref025]\].

For the SDMD cohort of over 98,000 drug treatment clients in Scotland, we have confirmed that a high DRD risk soon after hospital-discharge applies in 2006--2010 as it did in 1996--2006 \[[@pone.0141073.ref014]\]. Length of hospital-stay had no effect on DRD-rate, discharge-diagnosis had an effect (as did reported misuse of alcohol) but neither was as discriminatory as the behavioral risk-factor of having ever injected.
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